Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes

Immunology

Volumn 150, Issue 1, 2017, Pages 55-63

  Kundu, Rhiannon ^a,b   Theodoraki, Aikaterini ^a   Haas, Carolin T ^a   Zhang, Yanjing ^a   Chain, Benjamin ^a   Kriston Vizi, Janos ^a   Noursadeghi, Mahdad ^a   Khoo, Bernard ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

dendritic cells; macrophages; mitogen activated protein kinase; monocytes; nuclear factor B; vitamin D

Indexed keywords

CD14 ANTIGEN; COLECALCIFEROL; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VITAMIN D; LIPOPOLYSACCHARIDE;

ADOLESCENT; ARTICLE; BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; CELL SPECIFICITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MONONUCLEAR PHAGOCYTE; MYELOID DENDRITIC CELL; OSTEOPENIA; OSTEOPOROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADULT; AGED; ANTIBODY SPECIFICITY; CELL CULTURE; DENDRITIC CELL; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MIDDLE AGED; MONOCYTE; SIGNAL TRANSDUCTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; COHORT STUDIES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MACROPHAGES; MIDDLE AGED; MONOCYTES; NF-KAPPA B; ORGAN SPECIFICITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84990187745     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12669     Document Type: Article

References (20)

1. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006; 147:5542–8.
2. Kundu R, Chain BM, Coussens AK, Khoo B, Noursadeghi M. Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur J Immunol 2014; 44:1781–90.
3. Penna G, Adorini L. 1 α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405–11.
4. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183:5458–67.
5. + regulatory T cells through preferential expansion and usage of interleukin-2. Immunology 2014; 143:52–60.
6. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 2012; 189:5155–64.
7. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007;178:145–53.
8. Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188:2127–35.
9. Tsang J, Chain BM, Miller RF, Webb BLJ, Barclay W, Towers GJ, et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS Lond Engl 2009; 23:2255–63.
10. Le Bert N, Chain BM, Rook G, Noursadeghi M. DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway. PLoS One 2011;6:e18346 doi: 10.1371/journal.pone.0018346
11. Chain B. agilp: Agilent expression array processing package. [Internet]URL http://www.bioconductor.org/packages/release/bioc/html/agilp.html [accessed on May 2013].
12. Kwon AT, Arenillas DJ, Worsley Hunt R, Wasserman WW. oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3 Bethesda 2012; 2:987–1002.
13. Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, Katz DR. Quantitative imaging assay for NF-κB nuclear translocation in primary human macrophages. J Immunol Methods 2008; 329:194–200.
14. Sommer A, Fabri M. Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells. PLoS One 2015; 10:e0130395.
15. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003; 102:672–81.
16. Széles L, Keresztes G, Töröcsik D, Balajthy Z, Krenács L, Póliska S, et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 2009;182:2074–83.
17. Noursadeghi M, Tsang J, Miller RF, Straschewski S, Kellam P, Chain BM, et al. Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NF-κB activation pathway. J Immunol 2009; 182:319–28.
18. Tomlinson G, Chimalapati S, Pollard T, Lapp T, Cohen J, Camberlein E, et al. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol 2014; 193:3736–45.
19. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911–30.
20. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36:361–70.